“…Since the first report on the interaction between small molecules and G4 DNA in 1997 (Wang et al, 2010), many leading compounds that target G4 have been found, including anthraquinones (Sun et al, 1997;Perry et al, 1998aPerry et al, , 1998b, cationic porphyrins (Anantha et al, 1998;Han et al, 2001), perylene (Rossetti et al, 2002), benzoindoloquinolines (Alberti et al, 2002, ethidium derivatives (Koeppel et al, 2001), acridine derivatives (Harrison et al, 1999), piperazines (Riou et al, 2001), pentacyclicacridinium salts (Gowan et al, 2001), fluoroquinophenoxazines (Duan et al, 2001), and others. Most of these compounds have the same features: (1) a p-delocalized system that is able to stack on the face of a guanine quartet, (2) a partial positive charge that is able to lay in the center of the quartet, increasing stabilization by substituting the cationic charge of the potassium or sodium that would normally occupy that site, and (3) positively charged substituents to interact with the grooves and loops of G4 and the negatively charged backbone phosphates (Reed et al, 2006;Yang et al, 2011). In accordance with these desirable features, there are 3 interaction modes of G4-ligands and G4: (1) external stacking: ligands stack on the terminal Gquarter through p-p accumulation; (2) intercalating: ligands insert into the space of two G-quarters; and (3) groove binding: ligands bind to the grooves or loops of the G4.…”